Members of the House Government Reform Committee asked for information from the Food and Drug Administration and the Government Accountability Office on the FDA's oversight of the reprocessing of single-use medical devices, a controversial practice. While devicemakers say they cannot guarantee the safety of the practice, reprocessing single-use devices saves hospitals money and reprocessing companies say there is insufficient evidence to conclude the practice unsafe. The committee asked the FDA to describe by Jan. 3 the steps it takes to ensure the safety of reprocessed devices. A GAO report in 2000 called for more oversight of the industry. -- by Joseph Mantone
House committee seeks data on device reprocessing
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.